What are the major opportunities in the mRNA Therapeutics market? What are the strategies for the mRNA Therapeutics market?

For detailed insights on the major opportunities and strategies in the mRNA Therapeutics market, Read More

How does the mRNA Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on mRNA Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the mRNA Therapeutics market growth? SWOT analysis of the mRNA Therapeutics market.

For detailed insights on the key dynamics influencing the mRNA Therapeutics market growth and SWOT analysis of the mRNA Therapeutics industry, Read More

mRNA Therapeutics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

mRNA Therapeutics Market Report 2026

Name: mRNA Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Vaccines, Drugs), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications), By End Use (Hospitals And Clinics, Research Organizations, Other End Uses) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

mRNA Therapeutics Market Overview

• mRNA Therapeutics market size has reached to $35.9 billion in 2025

• Expected to grow to $42.32 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%

• Growth Driver: The Rise In Long-Lasting And Communicable Diseases Fueling Market Growth Due To Increasing Transmission And Need For Advanced Immunotherapies

• Market Trend: Innovative Personalized Cancer Vaccines Aim To Boost Immune Response And Improve Survival In High-Risk Melanoma

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under mRNA Therapeutics Market?

Messenger RNA (mRNA) therapeutics refers to a type of medical treatment that utilizes messenger RNA (mRNA) molecules to produce therapeutic proteins within the body. These therapeutics are used to prevent, treat, or cure diseases by directing cells to produce specific proteins that are needed for therapeutic effects.

The main products of mRNA therapeutics are vaccines and drugs. Vaccines in the mRNA therapeutics category refer to pharmaceutical products that use messenger RNA to instruct cells to produce proteins that trigger an immune response against specific diseases. Which can be useful for various applications including infectious diseases, oncology, rare genetic diseases, respiratory diseases, and others, end users are hospitals and clinics, research organizations, and others.

mRNA Therapeutics Market Global Report 2026 Market Report bar graph

What Is The mRNA Therapeutics Market Size and Share 2026?

The mrna therapeutics market size has grown steadily in recent years. It will grow from $35.9 billion in 2025 to $37.18 billion in 2026 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to breakthrough success of mrna vaccines in infectious diseases, advances in nucleic acid delivery technologies, increased understanding of gene expression control, early research validation of mrna-based protein synthesis, strong public funding for mrna research platforms.

What Is The mRNA Therapeutics Market Growth Forecast?

The mrna therapeutics market size is expected to see steady growth in the next few years. It will grow to $42.32 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to rising demand for targeted and personalized therapies, expansion of mrna applications in oncology and rare diseases, growing biopharmaceutical investment in mrna pipelines, increasing number of mrna drugs entering clinical trials, strategic partnerships between biotech firms and research organizations. Major trends in the forecast period include expansion of mrna therapeutics beyond vaccines, growing focus on protein replacement therapies using mrna, rising clinical pipeline for non-vaccine mrna drugs, increasing investment in lipid nanoparticle delivery systems, acceleration of end-to-end mrna manufacturing capabilities.

Book your 30 minutes free consultation with our research experts

Global mRNA Therapeutics Market Segmentation

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

What Is The Driver Of The mRNA Therapeutics Market?

The increasing prevalence of long-lasting and communicable diseases is expected to propel the growth of the mRNA therapeutics market going forward. Long-lasting and communicable diseases are illnesses that persist for extended periods and can spread between individuals, including conditions such as tuberculosis, HIV/AIDS, and hepatitis. The rise in these diseases is driven by factors such as increased global mobility and gaps in healthcare infrastructure, which contribute to greater transmission rates and hinder effective disease management. mRNA therapeutics support improved disease control by rapidly enabling the body to produce proteins that enhance immune responses, facilitating the accelerated development of targeted vaccines and treatments. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the increasing prevalence of long-lasting and communicable diseases is driving the growth of the mRNA therapeutics industry.

Key Players In The Global mRNA Therapeutics Market

Major companies operating in the mrna therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

Global mRNA Therapeutics Market Trends and Insights

Major companies operating in the mRNA therapeutics market are focusing on developing innovative solutions, such as personalized neoantigen vaccines, to enhance immune response and improve survival outcomes in cancer patients. Personalized neoantigen vaccines are cancer therapies designed for each patient, using unique tumor-specific mutations to stimulate the immune system to target and destroy cancer cells. For instance, in July 2023, Merck & Co., Inc., a US-based research-intensive biopharmaceutical company, partnered with Moderna Therapeutics, Inc., a US-based biotechnology company, to initiate a Phase 3 randomized clinical trial (V940-001) to evaluate mRNA-4157 (V940) in combination with KEYTRUDA® (pembrolizumab) as an adjuvant treatment for patients with resected high-risk (Stage IIB-IV) melanoma. This study follows positive results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial, which showed a meaningful benefit of the combination over KEYTRUDA alone in reducing recurrence and distant metastasis risk. The Phase 3 trial aims to confirm these findings by assessing relapse-free survival and distant metastasis-free survival as primary and secondary endpoints, respectively.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The mRNA Therapeutics Market?

In June 2025, BioNTech SE, a Germany-based biotechnology company, acquired CureVac N.V. for an undisclosed amount. With the acquisition, BioNTech SE aims to strengthen the research, development, manufacturing, and commercialization of mRNA-based cancer immunotherapy candidates, marking a key milestone in its oncology strategy to advance innovative cancer treatments and establish new standards of care in the coming years. CureVac N.V. is a Germany-based company that develops mRNA-based therapies.

Regional Insights

North America was the largest region in the mRNA therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the mRNA Therapeutics Market?

The mRNA therapeutics market consists of revenues earned by entities by providing services such as vaccine development, protein replacement therapies, gene editing, monoclonal antibody production, and cancer treatment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the mRNA Therapeutics Market Report 2026?

The mrna therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mrna therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

mRNA Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$37.18 billion
Revenue Forecast In 2035	$42.32 billion
Growth Rate	CAGR of 3.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Application, End Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus The
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. mRNA Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global mRNA Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. mRNA Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global mRNA Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of Mrna Therapeutics Beyond Vaccines

4.2.2 Growing Focus On Protein Replacement Therapies Using Mrna

4.2.3 Rising Clinical Pipeline For Non-Vaccine Mrna Drugs

4.2.4 Increasing Investment In Lipid Nanoparticle Delivery Systems

4.2.5 Acceleration Of End-To-End Mrna Manufacturing Capabilities

5. mRNA Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Research Organizations

5.3 Biotechnology Companies

5.4 Pharmaceutical Companies

5.5 Academic And Translational Research Institutes

6. mRNA Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global mRNA Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global mRNA Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global mRNA Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global mRNA Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global mRNA Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global mRNA Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. mRNA Therapeutics Market Segmentation

9.1. Global mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vaccines, Drugs

9.2. Global mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

9.3. Global mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Research Organizations, Other End Uses

9.4. Global mRNA Therapeutics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

9.5. Global mRNA Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

10. mRNA Therapeutics Market Regional And Country Analysis

10.1. Global mRNA Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global mRNA Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific mRNA Therapeutics Market

11.1. Asia-Pacific mRNA Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China mRNA Therapeutics Market

12.1. China mRNA Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India mRNA Therapeutics Market

13.1. India mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan mRNA Therapeutics Market

14.1. Japan mRNA Therapeutics Market Overview

14.2. Japan mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia mRNA Therapeutics Market

15.1. Australia mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia mRNA Therapeutics Market

16.1. Indonesia mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea mRNA Therapeutics Market

17.1. South Korea mRNA Therapeutics Market Overview

17.2. South Korea mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan mRNA Therapeutics Market

18.1. Taiwan mRNA Therapeutics Market Overview

18.2. Taiwan mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia mRNA Therapeutics Market

19.1. South East Asia mRNA Therapeutics Market Overview

19.2. South East Asia mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe mRNA Therapeutics Market

20.1. Western Europe mRNA Therapeutics Market Overview

20.2. Western Europe mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK mRNA Therapeutics Market

21.1. UK mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany mRNA Therapeutics Market

22.1. Germany mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France mRNA Therapeutics Market

23.1. France mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy mRNA Therapeutics Market

24.1. Italy mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain mRNA Therapeutics Market

25.1. Spain mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe mRNA Therapeutics Market

26.1. Eastern Europe mRNA Therapeutics Market Overview

26.2. Eastern Europe mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia mRNA Therapeutics Market

27.1. Russia mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America mRNA Therapeutics Market

28.1. North America mRNA Therapeutics Market Overview

28.2. North America mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA mRNA Therapeutics Market

29.1. USA mRNA Therapeutics Market Overview

29.2. USA mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada mRNA Therapeutics Market

30.1. Canada mRNA Therapeutics Market Overview

30.2. Canada mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America mRNA Therapeutics Market

31.1. South America mRNA Therapeutics Market Overview

31.2. South America mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil mRNA Therapeutics Market

32.1. Brazil mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East mRNA Therapeutics Market

33.1. Middle East mRNA Therapeutics Market Overview

33.2. Middle East mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa mRNA Therapeutics Market

34.1. Africa mRNA Therapeutics Market Overview

34.2. Africa mRNA Therapeutics Market, Segmentation By Product, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. mRNA Therapeutics Market Regulatory and Investment Landscape

36. mRNA Therapeutics Market Competitive Landscape And Company Profiles

36.1. mRNA Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. mRNA Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. mRNA Therapeutics Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

37. mRNA Therapeutics Market Other Major And Innovative Companies

Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd

38. Global mRNA Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The mRNA Therapeutics Market

40. mRNA Therapeutics Market High Potential Countries, Segments and Strategies

40.1 mRNA Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 mRNA Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 mRNA Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global mRNA Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global mRNA Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global mRNA Therapeutics Market, Supply Chain Analysis

Table 4: Global mRNA Therapeutics Market, Major Raw Material Providers

Table 5: Global mRNA Therapeutics Market, Major Resource Providers

Table 6: Global mRNA Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global mRNA Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global mRNA Therapeutics Market, Key Technologies & Future Trends

Table 9: Global mRNA Therapeutics Market, Major Trends

Table 10: Global mRNA Therapeutics Market, Major End Users

Table 11: Global mRNA Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global mRNA Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global mRNA Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global mRNA Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global mRNA Therapeutics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global mRNA Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global mRNA Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global mRNA Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global mRNA Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global mRNA Therapeutics Market - Company Scoring Matrix

Table 96: Pfizer Inc. Financial Performance

Table 97: Novartis AG Financial Performance

Table 98: Sanofi AG Financial Performance

Table 99: AstraZeneca plc Financial Performance

Table 100: GlaxoSmithKline plc Financial Performance

Table 101: Global mRNA Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 102: Global mRNA Therapeutics Market, Competitive Dashboard

Table 103: Global mRNA Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, mRNA Therapeutics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 105: Global, mRNA Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 106: Global, mRNA Therapeutics Market Size Gain ($ Billion), Segmentation By End Use, 2025 – 2030

List Of Figures

Figure 1: Global mRNA Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global mRNA Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global mRNA Therapeutics Market, Supply Chain Analysis

Figure 4: Global mRNA Therapeutics Market, Major Raw Material Providers

Figure 5: Global mRNA Therapeutics Market, Major Resource Providers

Figure 6: Global mRNA Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global mRNA Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global mRNA Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global mRNA Therapeutics Market, Major Trends

Figure 10: Global mRNA Therapeutics Market, Major End Users

Figure 11: Global mRNA Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global mRNA Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global mRNA Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global mRNA Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global mRNA Therapeutics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global mRNA Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global mRNA Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global mRNA Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global mRNA Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global mRNA Therapeutics Market - Company Scoring Matrix

Figure 96: Pfizer Inc. Financial Performance

Figure 97: Novartis AG Financial Performance

Figure 98: Sanofi AG Financial Performance

Figure 99: AstraZeneca plc Financial Performance

Figure 100: GlaxoSmithKline plc Financial Performance

Figure 101: Global mRNA Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global mRNA Therapeutics Market, Competitive Dashboard

Figure 103: Global mRNA Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, mRNA Therapeutics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 105: Global, mRNA Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 106: Global, mRNA Therapeutics Market Size Gain ($ Billion), Segmentation By End Use, 2025 – 2030

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

Latest Market Developments in Specialty Generics Industry: Forecast 2025–2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report 2026 - Global Outlook – By Type (RNA Interference (RNAi), RNA Antisense), By Technology (Enabling Technology, Enabled Technology), By Therapeutic Area (Oncology,...

RNA Targeting Small Molecules Therapeutics Market Report 2026 - Global Outlook – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonuclei...

mRNA Cancer Vaccines And Therapeutics Market Report 2026 - Global Outlook – By Type (Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas), By Application (Cancer, Other Applications), By End User (Hospitals A...

Nucleic Acid Based Gene Therapy Market Report 2026 - Global Outlook – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologie...

Antisense & RNAi Therapeutics Market Report 2026 - Global Outlook – By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), B...

RNA Targeting Small Molecule Drug Discovery Market Report 2026 - Global Outlook – By Target RNA Type (Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)), By Therapeutic Area (On...

Gene Therapy Market Report 2026 - Global Outlook – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis,...

Frequently Asked Questions

How big is the mRNA Therapeutics Market?

The mRNA Therapeutics market was valued at $35.9 billion in 2025, increased to $37.18 billion in 2026, and is projected to reach $42.32 billion by 2030.

What is the mRNA Therapeutics market growth?

The global mRNA Therapeutics market is expected to grow at a CAGR of 3.3% from 2026 to 2035 to reach $42.32 billion by 2035.

Who are the key players in mRNA Therapeutics market?

Some Key Players in the mRNA Therapeutics market Include, Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG .

What is the anticipated growth trend for the mRNA Therapeutics market?

Major trend in this market includes: Innovative Personalized Cancer Vaccines Aim To Boost Immune Response And Improve Survival In High-Risk Melanoma . For further insights on this market. request a sample here

Which region has the most growth potential in the mRNA Therapeutics market?

North America was the largest region in the mRNA therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.